Summary
Introduction. Human immunodeficiency virus (HIV) was firstly detected in 1980s. Due to lack of treatment options, HIV caused opportunistic infections that led patients to death. Newly emerged antiviral medical treatment has helped increasing the lifespan of patients infected with HIV virus. However, because of increasing life expectancy of these patients, cardiovascular diseases have become the main cause of death.
Summary
Objective. The aim of this study is to review the latest literature and guidelines for assessing the risk of cardiovascular disease in patients with diabetes.
Frederikson’s classification of dyslipoproteinemias is based on clinical features and electrophoretic or ultracentrifugal pattern of lipoprotein fractions. It was recognized as the international standard of dyslipoproteinemia classification in 1972 by the World Health Organization. Type I dyslipoproteinemia is represented by three rare genetic disorders, i.e., familial lipoprotein lipase deficiency, familial apolipoprotein C-II deficiency and lipoprotein lipase deficiency due to familial inhibitor of lipoprotein lipase, which are inherited in autosomal recessive pattern.
Background. Cardiovascular diseases (CVD) are the main mortality cause in Lithuania. The Lithuanian CVD mortality rate is nearly two times higher as compared to the old member states of EU and it is possibly due to several reasons: different lifestyle habits and/or genetic factors. The aim of this study was to investigate the relation between cardiovascular diseases, risk factors and biochemical markers of atherosclerosis in the Lithuanian population.
